Wang‐Huei Sheng

9.6k total citations · 1 hit paper
294 papers, 6.9k citations indexed

About

Wang‐Huei Sheng is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Wang‐Huei Sheng has authored 294 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Infectious Diseases, 131 papers in Epidemiology and 43 papers in Molecular Medicine. Recurrent topics in Wang‐Huei Sheng's work include Antibiotic Resistance in Bacteria (43 papers), HIV/AIDS drug development and treatment (32 papers) and Pneumocystis jirovecii pneumonia detection and treatment (31 papers). Wang‐Huei Sheng is often cited by papers focused on Antibiotic Resistance in Bacteria (43 papers), HIV/AIDS drug development and treatment (32 papers) and Pneumocystis jirovecii pneumonia detection and treatment (31 papers). Wang‐Huei Sheng collaborates with scholars based in Taiwan, United States and China. Wang‐Huei Sheng's co-authors include Shan‐Chwen Chang, Yee‐Chun Chen, Jann‐Tay Wang, Po‐Ren Hsueh, Chien‐Ching Hung, Hsin‐Yun Sun, Szu‐Min Hsieh, Yu‐Chung Chuang, Chong‐Jen Yu and Aristine Cheng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Wang‐Huei Sheng

287 papers receiving 6.7k citations

Hit Papers

Mycobacterium abscessusComplex Infections in Humans 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wang‐Huei Sheng Taiwan 45 2.9k 2.7k 1.5k 800 728 294 6.9k
Javier Ariza Spain 51 3.4k 1.2× 1.8k 0.7× 2.1k 1.4× 1.6k 2.1× 858 1.2× 178 8.1k
Satoshi Ichiyama Japan 39 2.4k 0.8× 1.9k 0.7× 1.7k 1.1× 665 0.8× 1.0k 1.4× 217 5.8k
Mario Venditti Italy 54 4.3k 1.5× 3.8k 1.4× 2.2k 1.4× 1.1k 1.4× 1.1k 1.5× 281 9.7k
Irving Nachamkin United States 48 2.0k 0.7× 3.4k 1.3× 1.2k 0.8× 367 0.5× 858 1.2× 195 8.6k
Hanan H. Balkhy Saudi Arabia 43 1.7k 0.6× 3.6k 1.3× 1.3k 0.9× 304 0.4× 583 0.8× 154 8.0k
Pere Coll Spain 39 2.5k 0.9× 1.4k 0.5× 1.1k 0.7× 638 0.8× 493 0.7× 156 4.5k
Cheng‐Hsun Chiu Taiwan 49 2.8k 1.0× 2.9k 1.1× 1.9k 1.3× 731 0.9× 1.7k 2.4× 456 10.3k
Mi‐Na Kim South Korea 42 2.9k 1.0× 3.2k 1.2× 1.1k 0.7× 650 0.8× 1.4k 1.9× 341 6.5k
Henrik Carl Schønheyder Denmark 50 4.6k 1.6× 3.3k 1.2× 552 0.4× 1.3k 1.6× 823 1.1× 356 9.8k
Francesc Marco Spain 54 5.4k 1.9× 3.7k 1.4× 2.4k 1.6× 822 1.0× 1.0k 1.4× 289 10.1k

Countries citing papers authored by Wang‐Huei Sheng

Since Specialization
Citations

This map shows the geographic impact of Wang‐Huei Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang‐Huei Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang‐Huei Sheng more than expected).

Fields of papers citing papers by Wang‐Huei Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wang‐Huei Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang‐Huei Sheng. The network helps show where Wang‐Huei Sheng may publish in the future.

Co-authorship network of co-authors of Wang‐Huei Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wang‐Huei Sheng. A scholar is included among the top collaborators of Wang‐Huei Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wang‐Huei Sheng. Wang‐Huei Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhou, et al.. (2025). Characteristics of plastic bronchitis in children with infectious pneumonia. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 51(1). 24–24. 3 indexed citations
2.
Yeh, Yi‐Chen, et al.. (2024). Stress coping and resilience of frontline nurses under the emergency infectious disease pandemic: A latent class analysis. Applied Nursing Research. 80. 151857–151857. 1 indexed citations
3.
Chen, Pao‐Yu, Yu‐Shan Huang, Yu‐Chung Chuang, et al.. (2024). Implication of genotypes for prognosis of Candida glabrata bloodstream infections. Journal of Antimicrobial Chemotherapy. 79(8). 2008–2016.
4.
Yang, Jia‐Ling, et al.. (2024). Evaluating Risk Factors for Clinical Failure Among Tigecycline-Treated Patients. Infection and Drug Resistance. Volume 17. 5387–5393. 1 indexed citations
5.
Hsieh, Ming‐Ju, Nin‐Chieh Hsu, Yu‐Feng Lin, et al.. (2021). Developing and validating a model for predicting 7-day mortality of patients admitted from the emergency department: an initial alarm score by a prospective prediction model study. BMJ Open. 11(1). e040837–e040837. 3 indexed citations
6.
Hsu, Wan‐Ting, et al.. (2021). Risk of out-of-hospital cardiac arrest among sepsis survivors in Taiwan: analysis of a nationwide population-based cohort. BMJ Open. 11(9). e051502–e051502. 2 indexed citations
7.
Hsu, Nin‐Chieh, et al.. (2021). Integrated approach for multimorbid patients in a hospitalist setting: Survival analysis of a two-year prospective study. Journal of the Formosan Medical Association. 121(2). 473–481. 2 indexed citations
8.
Liu, Wang-Da, Sui‐Yuan Chang, Sui‐Yuan Chang, et al.. (2020). Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics. Journal of the Formosan Medical Association. 120(5). 1269–1273. 4 indexed citations
9.
Wang, Jann‐Tay, Wang‐Huei Sheng, Yi‐Hsuan Chen, et al.. (2020). Chlorhexidine bathing to prevent healthcare-associated vancomycin-resistant Enterococcus infections: A cluster quasi-experimental controlled study at intensive care units. Journal of the Formosan Medical Association. 120(3). 1014–1021. 4 indexed citations
10.
Sheng, Wang‐Huei, et al.. (2020). Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. Journal of the Formosan Medical Association. 120(1). 311–317. 15 indexed citations
11.
Cheng, Aristine, et al.. (2019). Selected Mutations by Nemonoxacin and Fluoroquinolone Exposure Among Relevant Gram-Positive Bacterial Strains in Taiwan. Microbial Drug Resistance. 26(2). 110–117. 10 indexed citations
12.
Huang, Sung‐Hsi, Yu‐Chung Chuang, Yi‐Chien Lee, et al.. (2019). Lumbar puncture for non-HIV-infected non-transplant patients with cryptococcosis: Should it be mandatory for all?. PLoS ONE. 14(8). e0221657–e0221657. 5 indexed citations
13.
Chiang, Cho‐Han, Sung‐Ching Pan, Keisuke Matsuda, et al.. (2018). Healthcare-associated infections in intensive care units in Taiwan, South Korea, and Japan: recent trends based on national surveillance reports. Antimicrobial Resistance and Infection Control. 7(1). 129–129. 34 indexed citations
14.
Huang, Li‐Min, Luan‐Yin Chang, Ping‐Ing Lee, et al.. (2014). Central venous catheter-associated bloodstream infections in pediatric hematology–oncology patients and effectiveness of antimicrobial lock therapy. Journal of Microbiology Immunology and Infection. 48(6). 639–646. 27 indexed citations
15.
Hsieh, Szu‐Min, Sung‐Ching Pan, Sui‐Yuan Chang, et al.. (2013). Differential Impact of Resistance-Associated Mutations to Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on HIV-1 Replication Capacity. AIDS Research and Human Retroviruses. 29(8). 1117–1122. 2 indexed citations
16.
Liou, Jyh‐Ming, Chi‐Yang Chang, Wang‐Huei Sheng, et al.. (2010). Genotypic Resistance in Helicobacter pylori Strains Correlates with Susceptibility Test and Treatment Outcomes after Levofloxacin- and Clarithromycin-Based Therapies. Antimicrobial Agents and Chemotherapy. 55(3). 1123–1129. 55 indexed citations
17.
Ho, Ya‐Chi, Tiffany Ting‐Fang Shih, Yu‐Hui Lin, et al.. (2007). Osteonecrosis in Patients with Human Immunodeficiency Virus Type 1 Infection in Taiwan. Japanese Journal of Infectious Diseases. 60(6). 382–386. 11 indexed citations
18.
Liao, Chun‐Hsing, Wang‐Huei Sheng, Yee‐Chun Chen, et al.. (2007). Predictive value of the serum bactericidal test for mortality in patients infected with multidrug-resistant Acinetobacter baumannii. Journal of Infection. 55(2). 149–157. 11 indexed citations
19.
Chang, Sui‐Yuan, Wang‐Huei Sheng, Chun‐Nan Lee, et al.. (2006). Molecular Epidemiology of HIV Type 1 Subtypes in Taiwan: Outbreak of HIV Type 1 CRF07 BC Infection in Intravenous Drug Users. AIDS Research and Human Retroviruses. 22(11). 1055–1066. 21 indexed citations
20.
Hung, Chien‐Ching, et al.. (2005). Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. International Journal of STD & AIDS. 16(4). 302–306. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026